PathFree New York Investor Presentation Series
Three Complete PathFree Presentations in New York
Each private evening gives a new invited investor group direct access to Dr. Perry M. Brunette, Ph.D., CEO & Founder of PathFree Technologies. Dr. Brunette will personally present PathFree Technologies and its flagship product, AiMediQ™ powered by datasyteAI™, explain the company’s clinical and commercial vision, discuss the offering, and answer investor questions in real time.
The Program
The Complete Evening Program
Each evening follows the same complete presentation format for a different invited audience.
01
Private Welcome and Introductions
Borex Capital facilitates introductions between PathFree leadership and the invited prospective investors.
02
The Clinical Problem
Dr. Brunette explains the pressures, fragmentation, and cognitive burden present during Code Blue and emergency cardiac-response workflows.
03
PathFree Technologies
An introduction to the company, its mission, development strategy, and long-term vision.
04
AiMediQ™ powered by datasyteAI™
A focused presentation of PathFree’s flagship product, intended workflow, product architecture, and development-stage capabilities.
05
Business and Commercial Strategy
Discussion of the proposed hardware, software, service, deployment, and recurring-revenue model.
06
The Investment Opportunity
An explanation of the applicable PathFree offering, use of proceeds, campaign structure, and next-step process.
07
Direct Investor Q&A
Prospective investors may ask Dr. Brunette questions about the company, product, market, development pathway, business strategy, leadership, and offering.
08
Confidential Follow-Up
Interested and eligible prospective investors may request approved materials, management follow-up, and access to applicable diligence information.
Each evening follows the same complete presentation format for a different invited audience. Agendas, sequencing, and content are indicative and are not final or guaranteed.
PathFree Technologies is the sole presenting company. Dr. Perry M. Brunette, Ph.D., CEO & Founder, is expected to lead the company presentation and investor Q&A.
Exclusivity
PathFree owns the stage.
PathFree Technologies is the sole presenting company during the three-evening program.
- Private dining room; invitation-led attendance
- Complete PathFree presentation delivered by Dr. Perry M. Brunette, Ph.D., CEO & Founder
- No public recording, no press, no third-party distribution of materials
- Attendance by invitation following review of an information request
The Audience
An invited room, assembled for one presenting company
30 targeted investors are expected to be invited per evening; 90 invitations are contemplated across the three-evening program.
90 total invitations are contemplated across the three evenings, averaging 30 invitations per evening. Actual attendance may differ.
Borex Capital serves as an organizer and investor-introduction facilitator. Borex Capital is not a guarantor of attendance, investor interest, diligence, commitments, or capital formation. Prospective investors make independent investment decisions.
After the Evening
How a conversation becomes a process
- 01Presentation Evening
- 02Information Request
- 03Confidential Materials
- 04Management Follow-Up
- 05Diligence
- 06Potential Next Steps
This sequence is illustrative. Invitations, attendance, receipt of materials, diligence activity, commitments, and investment outcomes are not guaranteed at any stage.
Attendance at an evening presentation is informational. It is not an offer, a solicitation, or an acceptance of any subscription, and no securities are sold at the presentations.
Attendance
Seating across the three evenings is strictly limited.
Invitations are issued following review of an information request. Submitting a request creates no obligation of any kind, and does not guarantee an invitation.